Sharda Cropchem Limited has achieved its most successful year to date, delivering record-breaking PAT, EBITDA, and revenue for FY2025-26. Despite global macroeconomic headwinds, the company leveraged its asset-light business model and consistent investment in product registrations to drive growth. With 3,011 active product registrations and 1,004 registrations in the pipeline, the company remains optimistic about maintaining its growth momentum in FY2027, targeting revenue expansion in the range of 10% to 15%.
Record Financial Results
Sharda Cropchem has concluded FY2025-26 with historic financial milestones. Annual revenues climbed to INR 5,268 crore, representing a 22% year-on-year increase. Profitability also saw significant growth, with PAT reaching INR 681 crore, an impressive 124% surge compared to the previous fiscal year. The company remains in a strong financial position, reporting a debt-free status with cash and liquid investments totaling INR 702 crore as of March 31, 2026.
Quarterly Performance Highlights
For Q4 (January-March) FY2026, total revenues reached INR 2,065 crore, a 13% year-on-year growth. The agrochemical segment performed strongly, recording a 14% growth. Gross margins for the quarter expanded by 750 basis points to 37.3%, bolstered by operational discipline and a recovery in global demand. The board has recommended a final dividend of INR 9 per equity share, bringing the total dividend for the year to INR 15 per share.
Strategic Outlook and Market Presence
Management highlighted that the company’s asset-light model provides resilience in volatile environments. As of March 31, 2026, the company holds 3,011 product registrations, with 1,004 additional applications currently in the pipeline. Despite geopolitical tensions, the company continues to maintain stable supply chains, including deliveries to key markets like Europe, LATAM, and Ukraine. For FY2027, the company projects a 10% to 15% growth in business, maintaining a focus on high-margin product distribution and customer-centric market expansion.
Source: BSE
